Sensitive methods to define subtle memory decline capture intra‐individual hippocampal atrophy and increased cortical volumes in preclinical Alzheimer’s

Documenti analoghi

• Diagnostic blind spot in clinical manifestations: anosognosia trajectory in preclinical Alzheimer's is linked to core pathophysiology, astrocytic reactivity, and structural changes in cognitive control and self‐referential brain regions
  di: David López‐Martos, et al.
  Pubblicazione: (2025)
• Voxel‐wise longitudinal changes between amyloid PET and executive function subcomponents at the preclinical stage of the Alzheimer's continuum
  di: David López‐Martos, et al.
  Pubblicazione: (2025)
• Late motherhood linked to accelerated memory decline in amyloid‐positive cognitively unimpaired women
  di: Anna Brugulat‐Serrat, et al.
  Pubblicazione: (2025)
• Cerebral glucose metabolism and regional homogeneity as predictors of amyloid burden changes in preclinical AD
  di: Michalis Kassinopoulos, et al.
  Pubblicazione: (2025)
• Neurobiological correlates of grey matter morphometry changes in preclinical Alzheimer’s disease
  di: Wiesje Pelkmans, et al.
  Pubblicazione: (2024)